448 related articles for article (PubMed ID: 18809287)
1. The utility of the StarClose arterial closure device in patients with peripheral arterial disease.
Gray BH; Miller R; Langan EM; Joels CS; Yasin Y; Kalbaugh CA
Ann Vasc Surg; 2009; 23(3):341-4. PubMed ID: 18809287
[TBL] [Abstract][Full Text] [Related]
2. The use of the StarClose device for obtaining femoral artery hemostasis.
Rodriguez A; Katz SG
Vasc Endovascular Surg; 2011 Oct; 45(7):627-30. PubMed ID: 21646232
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.
Jaff MR; Hadley G; Hermiller JB; Simonton C; Hinohara T; Cannon L; Reisman M; Braden G; Fletcher DR; Zapien M; Chou TM; DiDonato K
Catheter Cardiovasc Interv; 2006 Nov; 68(5):684-9. PubMed ID: 17039509
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of StarClose SE Vascular Closure System in high-risk liver interventional oncology patients.
Gaba RC; Parvinian A; Trinos EM; Padayao SV; Francisco RM; Yap FY; Knuttinen MG; Owens CA; Bui JT
J Vasc Access; 2012; 13(4):415-20. PubMed ID: 22467152
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis.
Bangalore S; Vidi VD; Liu CB; Shah PB; Resnic FS
J Invasive Cardiol; 2011 May; 23(5):194-9. PubMed ID: 21562348
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of clip-based vs. suture mediated vascular closure for femoral access hemostasis: A prospective randomized single center study comparing the StarClose and the ProGlide device.
Klein-Wiele O; Baliota M; Kara K; Käunicke M; Schäfer H; Garbrecht M; Abdulghafor M; Garmer M; Hailer B
Catheter Cardiovasc Interv; 2018 Feb; 91(3):402-407. PubMed ID: 28500743
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of the StarClose vascular closure device in more than 1000 consecutive peripheral angioplasty procedures.
Spiliopoulos S; Katsanos K; Karnabatidis D; Diamantopoulos A; Nikolaos C; Siablis D
J Endovasc Ther; 2011 Jun; 18(3):435-43. PubMed ID: 21679086
[TBL] [Abstract][Full Text] [Related]
8. Multicenter safety and efficacy analysis of assisted closure after antegrade arterial punctures using the StarClose device.
Williams RE; Angel CY; Bourkaib R; Brenot P; Commeau P; Fisher RK; Jackson R; Kay CH; Le Dref O; Riou JY; Rose J; Macdonald S
J Endovasc Ther; 2007 Aug; 14(4):498-505. PubMed ID: 17696624
[TBL] [Abstract][Full Text] [Related]
9. Use of StarClose for brachial artery closure after percutaneous endovascular interventions.
Puggioni A; Boesmans E; Deloose K; Peeters P; Bosiers M
Vascular; 2008; 16(2):85-90. PubMed ID: 18377837
[TBL] [Abstract][Full Text] [Related]
10. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
[TBL] [Abstract][Full Text] [Related]
11. FemoSeal
Gabrielli R; Rosati MS; Millarelli M; Dante A; Maiorano M; Musilli A; Chiappa R; Ventura M
Ann Vasc Surg; 2018 Aug; 51():18-24. PubMed ID: 29678650
[TBL] [Abstract][Full Text] [Related]
12. StarClose vascular closure device: prospective study on 222 deployments in an interventional radiology practice.
Imam A; Carter RM; Phillips-Hughes J; Boardman P; Uberoi R
Cardiovasc Intervent Radiol; 2007; 30(4):738-42. PubMed ID: 17587083
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of antegrade common femoral artery access closure using the Angio-Seal device: experience with 1889 interventions for critical limb ischemia in diabetic patients.
Lupattelli T; Tannouri F; Garaci FG; Papa G; Pangos M; Somalvico F; Caravaggi C; Faglia E
J Endovasc Ther; 2010 Jun; 17(3):366-75. PubMed ID: 20557177
[TBL] [Abstract][Full Text] [Related]
14. StarClose vascular closure system (VCS) is safe and effective in patients who ambulate early following successful femoral artery access closure--results from the RISE clinical trial.
Burke MN; Hermiller J; Jaff MR
Catheter Cardiovasc Interv; 2012 Jul; 80(1):45-52. PubMed ID: 22162141
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of StarClose vascular closure device in patients with first and recurrent femoral punctures.
Tay EL; Co M; Tai BC; Lee YP; Low A; Lim YT; Tan HC; Lee CH
J Interv Cardiol; 2008 Feb; 21(1):67-73. PubMed ID: 18254789
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization.
Hermiller J; Simonton C; Hinohara T; Lee D; Cannon L; Mooney M; O'Shaughnessy C; Carlson H; Fortuna R; Yarbrough CA; Zapien M; Chou T
J Invasive Cardiol; 2005 Oct; 17(10):504-10. PubMed ID: 16204741
[TBL] [Abstract][Full Text] [Related]
17. Early ambulation after percutaneous femoral access with use of closure devices and hemostatic agents.
Engelbert TL; Scholten A; Thompson K; Spivack A; Kansal N
Ann Vasc Surg; 2010 May; 24(4):518-23. PubMed ID: 20451795
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis.
Branzan D; Sixt S; Rastan A; Schwarz T; Schwarzwälder U; Bürgelin K; Noory E; Beyersdorf F; Zeller T
J Endovasc Ther; 2009 Aug; 16(4):475-82. PubMed ID: 19702352
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition.
Ruygrok PN; Ormiston JA; Stewart JT; Webster MW; El Jack S; Simpson-Plaumann S; Kay IP; Chou TM
Catheter Cardiovasc Interv; 2005 Oct; 66(2):185-91. PubMed ID: 16152652
[TBL] [Abstract][Full Text] [Related]
20. Re-access complication with a Starclose device.
Varghese R; Chess D; Lasorda D
Catheter Cardiovasc Interv; 2009 Jun; 73(7):899-901. PubMed ID: 19455658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
